相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
A robust and efficient method for Mendelian randomization with hundreds of genetic variants
Stephen Burgess et al.
NATURE COMMUNICATIONS (2020)
Short or Long Sleep Duration and CKD: A Mendelian Randomization Study
Sehoon Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Homocysteine and small vessel stroke: A mendelian randomization analysis
Susanna C. Larsson et al.
ANNALS OF NEUROLOGY (2019)
A catalog of genetic loci associated with kidney function from analyses of a million individuals
Matthias Wuttke et al.
NATURE GENETICS (2019)
An evidence-based approach to globally assess the covariate-dependent effect of the MTHFR single nucleotide polymorphism rs1801133 on blood homocysteine: a systematic review and meta-analysis
Huifeng Jin et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2018)
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Neil M. Davies et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Neil M. Davies et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Homocysteine-lowering interventions for preventing cardiovascular events
Arturo J. Marti-Carvajal et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
Anna Fry et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique
Fernando Pires Hartwig et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease The Renal Substudy of the China Stroke Primary Prevention Trial
Xin Xu et al.
JAMA INTERNAL MEDICINE (2016)
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health
Henrieta Skovierova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China The CSPPT Randomized Clinical Trial
Yong Huo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease
Joyce B. J. van Meurs et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Genetic Architecture of Vitamin B12 and Folate Levels Uncovered Applying Deeply Sequenced Large Datasets
Niels Grarup et al.
PLOS GENETICS (2013)
Use of Mendelian randomisation to assess potential benefit of clinical intervention
Stephen Burgess et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease: A Meta-Analysis
Xianhui Qin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Homocysteine to Hydrogen Sulfide or Hypertension
Utpal Sen et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2010)
Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy A Randomized Controlled Trial
Andrew A. House et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Homocysteine as a Risk Factor for Cardiovascular Disease in Patients Treated by Dialysis: A Meta-analysis
Judith Heinz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Homocysteine lowering and cardiovascular events after acute myocardial infarction
KH Bonaa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Relationship between homocysteine and mortality in chronic kidney disease
V Menon et al.
CIRCULATION (2006)
Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy
AN Friedman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus
M Soinio et al.
ANNALS OF INTERNAL MEDICINE (2004)
Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress
KKW Au-Yeung et al.
CIRCULATION RESEARCH (2004)
分享论文
